A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
University of Iowa
University of Wisconsin, Madison
University of Pennsylvania
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
St. Jude Children's Research Hospital
University of Chicago
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
The Netherlands Cancer Institute
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Institute of Oncology Ljubljana
Stanford University
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
First Affiliated Hospital of Zhejiang University
City of Hope Medical Center
Massachusetts General Hospital
Stanford University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Blue Earth Diagnostics
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Mayo Clinic
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Thomas Jefferson University
Stanford University
Kepler University Hospital
Memorial Sloan Kettering Cancer Center
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
City of Hope Medical Center
Blue Earth Diagnostics
University of Michigan Rogel Cancer Center
The Hospital for Sick Children
Memorial Sloan Kettering Cancer Center
Ottawa Heart Institute Research Corporation
Ruijin Hospital
University of Michigan Rogel Cancer Center
Stanford University